Valuation — not yet established
No valuation for Vor Biopharma is on record yet — no priced round, mark, or trade has surfaced in our sources. Total raised ($430.6M) and the funding record below are the closest available signals.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
See the evidence behind this price
- ·Post-money valuations for all 5 rounds
- ·Watchlist + deal alerts for Vor Biopharma
Create free account
No card required
Funding history
5 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Dec 2025 | PIPE | $150.0M | ▮ | ▮ |
| Jun 2025 | PIPE | $175.0M | ▮ | ▮ |
| Dec 2024 | PIPE | $55.5M | ▮ | ▮ |
| Dec 2022 | PIPE | $50.0M | ▮ | ▮ |
| Jun 2020 | Later Stage VC | $110.1M | ▮ | ▮ |
How Vor Biopharma's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Vor Biopharma, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →
Frequently asked
- How much has Vor Biopharma raised?
- Vor Biopharma has raised $430.6M in total funding across 5 recorded rounds.
- When did Vor Biopharma last raise?
- Vor Biopharma last raised in Dec 2025 (PIPE), raising $150.0M.